Cogstate Limited
ASX: CGS.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Bradley John O'Connor
- Employees
- 147
- Headquarters
- Melbourne, Australia
- IPO year
- 2004
- Market cap
- A$405.3M
- Website
- https://www.cogstate.com
Loading CGS…
Loading profile data…Frequently asked questions about CGS
What does Cogstate Limited (CGS.AX) do?
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Cl...
Where does CGS.AX trade?
Cogstate Limited (CGS.AX) trades on the Australian Securities Exchange.
What sector is CGS.AX in?
Cogstate Limited (CGS.AX) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Cogstate Limited?
Bradley John O'Connor is the chief executive officer of Cogstate Limited (CGS.AX).
Where is Cogstate Limited headquartered?
Cogstate Limited is headquartered in Australia.
Does CGS.AX pay a dividend?
Yes — Cogstate Limited (CGS.AX) paid a trailing twelve-month dividend of AUD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CGS.AX go public?
Cogstate Limited (CGS.AX) completed its initial public offering in 2004.